- Report
- December 2024
- 144 Pages
Global
From €3506EUR$3,950USD£3,045GBP
- Report
- July 2025
- 350 Pages
Global
From €4393EUR$4,949USD£3,815GBP
- Report
- June 2025
- 150 Pages
Global
From €2396EUR$2,699USD£2,080GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2476EUR$2,789USD£2,150GBP
- Report
- June 2025
- 150 Pages
Global
From €2396EUR$2,699USD£2,080GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2476EUR$2,789USD£2,150GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2476EUR$2,789USD£2,150GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2476EUR$2,789USD£2,150GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2476EUR$2,789USD£2,150GBP
- Report
- June 2025
- 150 Pages
Global
From €2396EUR$2,699USD£2,080GBP
- Report
- June 2025
- 150 Pages
Global
From €2396EUR$2,699USD£2,080GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2476EUR$2,789USD£2,150GBP
- Report
- June 2025
- 400 Pages
Global
From €4393EUR$4,949USD£3,815GBP
- Report
- May 2025
- 300 Pages
Global
From €4393EUR$4,949USD£3,815GBP
- Report
- January 2025
- 250 Pages
Global
From €4437EUR$4,999USD£3,853GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2476EUR$2,789USD£2,150GBP
- Report
- June 2025
- 400 Pages
Global
From €4393EUR$4,949USD£3,815GBP
- Report
- September 2025
- 142 Pages
Global
From €3500EUR$4,224USD£3,146GBP
- Report
- August 2025
- 98 Pages
Global
From €3500EUR$4,224USD£3,146GBP
- Report
- May 2025
- 90 Pages
Global
From €3500EUR$4,224USD£3,146GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more